EGFR and non-small cell lung carcinoma: Validated in a cohort of 412 NSCLC patients, the model achieved an AUC of 0.93 for EGFR mutation prediction and first identified a specific association between “ground-glass opacity” on CT imaging and the EGFR L858R mutation.